William E. Steinkrauss
Nessuna posizione attualmente
Patrimonio netto: 45 328 $ in data 31/03/2024
Storia della carriera di William E. Steinkrauss
Precedenti posizioni note di William E. Steinkrauss
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CURIS, INC. | Chief Administrative Officer | 01/01/2022 | 05/08/2022 |
| Comptroller/Controller/Auditor | 23/03/2019 | 10/09/2019 | |
| Director of Finance/CFO | 10/09/2019 | 05/08/2022 | |
| Treasurer | 01/01/2019 | 01/09/2019 | |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Corporate Officer/Principal | 01/06/2015 | 01/08/2016 |
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/11/2012 | 01/05/2015 |
Formazione di William E. Steinkrauss
| Boston College | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Administrative Officer | 1 |
| Comptroller/Controller/Auditor | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CURIS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
